A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
Abstract The origins of the major classes of current anti-emetics are examined. Serendipity is a recurrent theme in discovery of…
chemotherapy-induced nausea and vomiting
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
Abstract Purpose: Oral cannabinoids (i.e., dronabinol, nabilone) containing the active component of marijuana, delta(Δ)9-tetrahydrocannabinol (THC), are available for the treatment…
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
Abstract Background: The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and…
Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
Abstract Despite the advent of classic anti-emetics, chemotherapy-induced nausea is still problematic, with vomiting being somewhat better managed in the…
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
Abstract Chemotherapy-induced nausea and vomiting (CINV) is one of the most common symptoms feared by patients, but may be prevented…
Cannabis hyperemesis syndrome: A case report review of treatment
Abstract Introduction: Cannabis is the most common illegal substance used in the world. The psychoactive nature of cannabis is primarily…
Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy
Abstract Prevention of chemotherapy-induced nausea and vomiting (CINV) is a key component of treatment for patients with cancer. Guidelines are…
Association of Marijuana Use and Cyclic Vomiting Syndrome
Abstract Cannabis use has become one of the most commonly abused drugs in the world. It is estimated that each…